Philadelphia, December 11, 2025
New York Gastroenterology Associates has formed a partnership with Proscia to implement the Concentriq software platform, transitioning to digital pathology. This collaboration emphasizes the integration of AI for enhanced diagnostic efficiency and improved research collaborations in gastroenterology. The move signifies a shift from traditional methods to advanced technology in disease profiling, ultimately benefiting patient care and outcomes.
Philadelphia, PA – New York Gastroenterology Associates (NYGA) has announced a significant partnership with Proscia to implement the Concentriq software platform, a move geared towards enhancing diagnostic efficiency and strengthening research collaborations within the gastroenterology field. This transition marks a pivotal shift from traditional microscope-based methods to advanced digital pathology, promising high-resolution, data-rich images that offer detailed profiles of diseases, particularly cancer.
The integration of artificial intelligence (AI) into the diagnostic process stands as a cornerstone of this new partnership. By leveraging AI, NYGA expects to significantly accelerate diagnoses and support precision medicine initiatives. David Hertz, NYGA’s Chief Operating Officer, highlighted the strategic importance of adopting digital pathology in gastroenterology, underlining Proscia’s platform as a bridge between current operational needs and future growth aspirations.
Streamlined Pathology Workflows
Proscia’s Concentriq platform is engineered to streamline pathology workflows, facilitating accurate and timely results from pathologists. Its design supports integration not only with laboratory operations but also with life sciences organizations, thereby enhancing collaboration across various research and clinical trial initiatives. The implications of this adoption align perfectly with a broader national trend towards digital pathology, which is increasingly becoming essential for improved diagnostic precision and collaborative research efforts.
This partnership also accentuates NYGA’s commitment to advancing medical knowledge through active participation in clinical research and studies. As a leading independent gastroenterology practice in New York City, NYGA is recognized for its comprehensive expertise in gastrointestinal health, including specialized services in colon cancer screening, inflammatory bowel disease management, and hepatology.
Advancements in Medical Technology
Proscia is a company on the forefront of pathology AI development, dedicated to enhancing precision medicine through data and AI applications that improve patient outcomes. Its platform has garnered a strong reputation within a global network of laboratories and pharmaceutical companies. The collaboration between NYGA and Proscia is indicative of a significant advancement in modernizing pathology practices that could potentially revolutionize gastroenterological diagnostics.
The increasing reliance on digital solutions enhances NYGA’s capabilities, allowing for faster turnaround times for diagnoses, thereby directly benefiting patient care. The industry’s shift towards technology, particularly in pathology, serves to highlight the strengths of private sector innovation in healthcare.
Key Features of Digital Pathology
Digital pathology is transforming how medical professionals access and analyze diagnostic data. By converting glass slides of tissue samples into digital images, pathologists can examine samples remotely, collaborate with peers, and utilize AI-assisted tools for accurate diagnoses. This not only improves operational efficiencies but also plays a crucial role in elevating patient care standards.
Advanced AI algorithms aid pathologists by automatically detecting and classifying cellular structures, quantifying features, identifying patterns, and flagging potential abnormalities. These enhancements increase efficiency and reduce human error, ultimately supporting more accurate assessments across diverse cases.
The Future of Healthcare
This significant step toward adopting digital pathology signals a future where healthcare is driven by collaboration and technological partnership. As NYGA continues to integrate these advancements, the practice stands to not only improve patient outcomes but also contribute to the development of innovative therapies and diagnostic techniques in gastroenterology.
With the focus on innovation and resilience in healthcare, this partnership exemplifies how strategic investments in technology can unlock new opportunities for growth—both in terms of medical advancements and the proliferation of research collaborations that test the limits of current medical knowledge.
Conclusion
The collaboration between New York Gastroenterology Associates and Proscia epitomizes a convergence of technology and healthcare that promises to yield substantial benefits for patients and researchers alike. As this model of digital pathology continues to evolve, it invites stakeholders in the Philadelphia community and beyond to engage actively in fostering innovation that supports better health outcomes. Embracing these technological advancements is not only about improving patient care but also about nurturing a vibrant ecosystem that encourages entrepreneurial strategies within the healthcare sector.
Frequently Asked Questions
What is digital pathology?
Digital pathology is the process of converting glass slides with tissue samples into digital images that can be viewed, managed, shared, and analyzed on a computer. It enables pathologists to examine tissue samples remotely, collaborate with colleagues, and use AI-assisted tools for more accurate diagnoses.
How does AI improve pathology analysis?
AI algorithms can assist pathologists by automatically detecting and classifying cellular structures, quantifying features, identifying patterns, and flagging potential abnormalities. This can increase efficiency, reduce human error, and provide quantitative data that might not be apparent to the human eye.
Is Proscia’s Concentriq platform compliant with healthcare and security regulations?
Yes, Proscia’s Concentriq platform is designed to meet the highest standards of data security and privacy, ensuring sensitive pathology data remains protected throughout the entire analysis workflow. It implements multi-layered security measures that adhere to international healthcare regulations.
Can Proscia’s Concentriq platform integrate with existing laboratory systems?
Absolutely. Proscia’s Concentriq platform is built with interoperability in mind and can integrate with most Laboratory Information Systems (LIS), Picture Archiving and Communication Systems (PACS), and other healthcare IT infrastructure. The platform is easily adaptable by institutions due to its simplicity.
What types of tissue samples can be analyzed using Proscia’s Concentriq platform?
Proscia’s Concentriq platform is designed to analyze a wide range of tissue samples, providing detailed and accurate assessments to support various diagnostic and research applications.
Do I need special hardware to use Proscia’s Concentriq platform?
While Proscia’s Concentriq platform works with most modern whole slide scanners, it is recommended to use specific scanner models for optimal results. For viewing and analysis, any modern computer with sufficient RAM and a good quality display will work. Proscia’s team can provide detailed specifications based on your expected usage volume.
| Feature | Description |
|---|---|
| High-Resolution Imaging | Provides detailed, data-rich images for precise disease profiling. |
| AI Integration | Utilizes artificial intelligence to enhance diagnostic accuracy and efficiency. |
| Interoperability | Seamlessly integrates with existing laboratory information systems and workflows. |
| Collaboration Tools | Facilitates real-time collaboration among pathologists and researchers. |
| Data Security | Ensures compliance with international healthcare regulations to protect sensitive data. |
Deeper Dive: News & Info About This Topic
HERE Resources
Author: STAFF HERE PHILADELPHIA WRITER
The PHILADELPHIA STAFF WRITER represents the experienced team at HEREPhiladelphia.com, your go-to source for actionable local news and information in Philadelphia, Philadelphia County, and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as Mummers Parade, Philadelphia Flower Show, and Thanksgiving Day Parade. Our coverage extends to key organizations like the Greater Philadelphia Chamber of Commerce and United Way of Greater Philadelphia, plus leading businesses in telecommunications, food services, and healthcare that power the local economy such as Comcast, Aramark, and Children's Hospital of Philadelphia. As part of the broader HERE network, we provide comprehensive, credible insights into Pennsylvania's dynamic landscape.
